NATHBIOGEN — Nath Bio-Genes (I) Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹3.86bn
- IN₹2.53bn
- IN₹3.65bn
- 43
- 63
- 73
- 66
Annual cashflow statement for Nath Bio-Genes (I), fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 568 | -634 | 362 | 416 | 406 |
| Depreciation | |||||
| Non-Cash Items | 69.8 | 983 | 99.3 | 70.1 | 92.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -654 | -210 | -107 | 228 | -360 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 11.1 | 170 | 384 | 746 | 176 |
| Capital Expenditures | -38.6 | -11.2 | -25.5 | -268 | -79.2 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -64.2 | -187 | -3.35 | -6.25 | 39.6 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -103 | -199 | -28.8 | -274 | -39.6 |
| Financing Cash Flow Items | -88.2 | -106 | -101 | -91.1 | -105 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 164 | -222 | -16.7 | -77.8 | -21.3 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 72.3 | -250 | 338 | 394 | 115 |